Abstract:BACKGROUND:Osteoporosis is one of the systemic features of COPD. A correlation between the emphysema phenotype of COPD and reduced bone mineral density (BMD) is suggested by some studies, however, the mechanisms underlying this relationship are unclear. Experimental studies indicate that IL-1β, IL-6 and TNF-α may play important roles in the etiology of both osteoporosis and emphysema. The OPG/RANK/RANKL system is an important regulator of bone metabolism, and participates in the development of post-menopausal osteoporosis. Whether the OPG/RANK/RANKL pathway is involved in the pathogenesis of osteoporosis in COPD has not been studied.METHODS:Eighty male patients (current or former smokers) completed a chest CT scan, pulmonary function test, dual x-ray absorptiometry measurements and questionnaires. Among these subjects, thirty patients with normal BMD and thirty patients with low BMD were selected randomly for measurement of IL-1β, IL-6, TNF-α (flow cytometry) and OPG/RANK/RANKL (ELISA). Twenty age-matched healthy volunteers were recruited as controls.RESULTS:Among these eighty patients, thirty-six had normal BMD and forty-four had low BMD. Age, BMI and CAT score showed significant differences between these two COPD groups (p < 0.05). The low-attenuation area (LAA%) in the lungs of COPD patients was negatively correlated with lumbar vertebral BMD (r = 0.741; p < 0.0001). Forward logistic regression analysis showed that only LAA% (p = 0.005) and BMI (p = 0.009) were selected as explanatory variables. The level of IL-1β was significantly higher in the COPD patients as compared to the normal controls (p < 0.05), but the difference between the two COPD groups did not reach significance. The levels of IL-6 and TNF-α among the three groups were significantly different (p < 0.05). The level of RANKL and the RANKL/OPG ratio were significantly higher in COPD patients with low BMD compared to those with normal BMD and the normal controls (p < 0.05), and correlated negatively with lumbar vertebral BMD, but positively with LAA%.CONCLUSIONS:Radiographic emphysema is correlated with low BMD in current and former smokers with COPD. IL-1β, IL-6, TNF-α, and the osteoporosis-related protein system OPG/RANK/RANKL may have some synergetic effects on emphysema and bone loss in COPD.

Delayed cortical bone healing due to impaired nuclear Nrf2 translocation in COPD mice

Inhibition of HIF-1α Restrains Fracture Healing Via Regulation of Autophagy in a Rat Model.

Nrf2 Deficiency Impairs Fracture Healing in Mice

Oxidative stress causes muscle structural alterations via p38 MAPK signaling in COPD mouse model

The impact of chronic obstructive pulmonary disease on bone strength

NRF2 is a Critical Regulator and Therapeutic Target of Metal Implant Particle-Incurred Bone Damage

[Establishment of a novel mouse mode of elastase-induced chronic obstructive pulmonary disease related osteoporosis]

Cigarette smoke-associated inflammation impairs bone remodeling through NFκB activation

A Low Expression of NRF2 Enhances Oxidative Stress and Autophagy in Myofibroblasts, Promoting Progression of Chronic Obstructive Pulmonary Disease

Prolonged Cadmium Exposure and Osteoclastogenesis: A Mechanistic Mouse and in Vitro Study

Disturbance of the OPG/RANK/RANKL Pathway and Systemic Inflammation in COPD Patients with Emphysema and Osteoporosis

Effects of elastase-induced emphysema on muscle and bone in mice

Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice

Optineurin Regulates NRF2-mediated Antioxidant Response in a Mouse Model of Paget's Disease of Bone

Increased RANKL Expression in Peripheral T Cells is Associated with Decreased Bone Mineral Density in Patients with COPD.

Smoking Alters Inflammation and Skeletal Stem and Progenitor Cell Activity During Fracture Healing in Different Murine Strains

Codonopsis Radix Inhibits the Inflammatory Response and Oxidative Stress in Chronic Obstructive Pulmonary Disease Mice through Regulation of the Nrf2/NF-κB Signaling Pathway

The mechanism of pyrroloquinoline quinone influencing the fracture healing process of estrogen-deficient mice by inhibiting oxidative stress

Inhibition of Ss-Catenin Signaling in Chondrocytes Induces Delayed Fracture Healing in Mice

CDDO-Me, Sulforaphane and Tbhq Attenuate the RANKL-induced Osteoclast Differentiation Via Activating the NRF2-mediated Antioxidant Response.

Downregulation of Krüppel-like factor 15 expression delays endochondral bone ossification during fracture healing